Browse drugs

… weakness that showed a striking and sustained improvement with pyridostigmine. His sister, however, presented with prominent myopathic featur…

… multicenter study included ARD patients who underwent CMR with gadolinium-based contrast at Yale University (retrospective cohort), University of Leeds …

…VEF 57.7%; RVEF 55.9%), the highest LGE prevalence (81.8%) with RVIP enrichment (45.5%), and the highest native T1 (1288 ms). Effect…

…inical practice. At the same time, this field is evolving, with approved drugs and earlier vascular interventions already changing the phenoty…

…er among those with ILD, although many within the normal range. Anti-reflux medication use was more frequent in ILD patients (69% vs. 43%, p=0.02), an…

…monary fibrosis in vivo. Translational studies demonstrate that monalizumab, a clinical-grade NKG2A inhibitor, reactivates patient-derived …

…isk of pre-capillary PH among SSc patients with vs. without the DNASE1L3 R206C variant in three longitudinal cohorts. (A) All SSc. (B) A…

… PreSSc was defined as the presence of SSc-specific antibodies (ACA, ATA, or ARA) in the absence of any other clinical manifestatio…

…d 8.1% VEDOSS criteria. Notably, 63% of patients were receiving proton pump inhibitors, and 9.6% were using prokinetics at the time of manometry.Among…

…to the advent of effective anti-HCV treatment and the disuse of protease inhibitors, HIV infection was no more associated to higher risk of rejecti…

…etic stem cell transplantation (allo HSCT). The introduction of letermovir (LTV) prophylaxis, which blocks the viral terminase complex and…

…ecommendations regarding on-demand PrEP use in CW. Knowledge of DoxyPEP was lower among CW/TW (27.4% vs 43.2%, p=0.036), whereas no dif…